New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
11:07 EDTEWEdwards Lifesciences backs FY14 EPS view 'around' $3.10, consensus $3.17
Sees FY14 total net sales growth 1%-10%. Sees FY14 gross profit margin approximately 73%. Sees FY14 free cash flow $325M-$425M. Guidance provided in slides presentation for William Blair & Company LLC Growth Stock Conference.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for EW

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use